Point mutations of the topoisomerase IIα gene in patients with small cell lung cancer treated with etoposide

Cancer Research

Volumn 56, Issue 6, 1996, Pages 1232-1236

  Kubo, Akihito ^a,c,d   Yoshikawa, Atsuko ^b   Hirashima, Tomonori ^b   Masuda, Noriyuki ^a   Takada, Minoru ^a   Takahara, Jiro ^c   Fukuoka, Masahiro ^b   Nakagawa, Kazuhiko ^a,e  

^a OSAKA PREFECTURAL MEDICAL CENTER FOR RESPIRATORY AND ALLERGIC DISEASES   (Japan)

^b OSAKA CITY GENERAL HOSPITAL   (Japan)

^c KAGAWA UNIVERSITY   (Japan)

^d Takamatsu National Hospital   (Japan)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING); ETOPOSIDE;

ADULT; AGED; ARTICLE; BRONCHUS BIOPSY; CLINICAL ARTICLE; DNA SEQUENCE; FEMALE; HUMAN; LUNG SMALL CELL CANCER; MALE; POINT MUTATION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM;

AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BASE SEQUENCE; CARCINOMA, SMALL CELL; CODON; DNA TOPOISOMERASES, TYPE II; DOXORUBICIN; ETOPOSIDE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POINT MUTATION; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA;

EID: 0029971429     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Danks, M. K., Schmidt, C. A., Cirtain, M. C., Suttle, D. P , and Beck, W. T. Altered catalytic activity of and DNA cleavage by DNA topoisomerase II from human leukemic cells selected for resistance to VM-26. Biochemistry, 27: 8861-8869, 1988.
2. Odaimi, M., Andersson, B. S., McCredie, K. B., and Beran, M. Drug sensitivity and cross-resistance of the 4′-(9-acridinylamino)methanesulfon-m-anisidide-resistant subline of HL-60 human leukemia. Cancer Res , 46: 3330-3333, 1986.
3. Sullivan, D M., Latham, M. D., Rowe, T C., and Ross, W. E. Purification and characterization of an altered topoisomerase II from a drug-resistant Chinese hamster ovary cell line. Biochemistry, 28: 5680-5687, 1989.
4. Beck, W T., and Danks, M. K. Multidrug resistance associated with alterations in topoisomerase II. In: M. Potmesil and K. W. Kohn (eds.), DNA Topoisomerases in Cancer, pp. 260-275 New York. Oxford University Press, 1991.
5. Walker, J. E., Saraste, M., Runswick, M. J., and Gay, N. J. Distantly related sequences in the α- and β-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold. EMBO J., 1, 945-951, 1982.
6. Wierenga, R. K., and Hol, W. G. J. Predicted nucleotide-binding properties of p21 protein and its cancer-associated variant. Nature (Lond), 302, 842-844, 1983.
7. Bugg, B. Y., Danks, M. K., Beck, W. T., and Suttle, D. P. Expression of a mutant DNA topoisomerase II in CCRF-CEM human leukemic cells selected for resistance to temposide. Proc. Natl. Acad. Sci. USA, 88: 7654-7658, 1991.
8. r 170,000 isozyme of DNA topoisomerase II in human tumor cells. Cancer Res., 53: 1373-1379, 1993.
9. Hinds, M., Deisseroth, K., Mayes, J , Altschuler, E., Jansen, R., Ledley, F. D., and Zwelling, L. A. Identification of a point mutation in the topoisomerase II gene from a human leukemia cell line containing an amsacrine-resistant form of topoisomerase II. Cancer Res., 51: 4729-4731, 1991
10. Lee, M-S., Wang, J. C., and Beran, M. Two independent amsacrine-resistant human myeloid leukemia cell lines share an identical point mutation in the 170kDa form of human topoisomerase II. J. Mol. Biol , 223: 837-843, 1992.
11. Chan, V. T. W., Ng, S-W., Eder, J. P. and Schnipper, L. E Molecular cloning and identification of a point mutation in the topoisomerase II cDNA from an etoposide-resistant Chinese hamster ovary cell line. J. Biol. Chem., 268: 2160-2165, 1993
12. Kaufman, S. H., Karp, J. E., Jones, R. J., Miller, C. B., Schneider, E., Zwelling, L. A., Cowan, K , Wendel, K., and Burke, P. J. Topoisomerase II levels and drug sensitivity in adult acute myelogenous leukemia. Blood, 83: 517-530, 1994.
13. Zelen, M. Keynote address on biostatistics and data retrieval. Cancer Chemother Rep. Part 3, 4: 31-42, 1973.
14. Chomczynski, P , and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem., 162: 156-159, 1987.
15. Tsai-Pflugfelder, M., Liu, L. F., Liu, A. A., Tewey, K. M., Whang-Peng, J , Knutsen, T., Huebner, K , Croce, C. M., and Wang, J. C Cloning and sequencing of cDNA encoding human DNA topoisomerase II and localization of the gene to chromosome region 17q21-22 Proc Natl Acad. Sci. USA, 85: 7177-7181, 1988.
16. Mashiyama, S., Sekiya, T., and Hayashi, K. Screening of multiple DNA samples for detection of sequence changes. Technique (Phila.), 2: 304-306, 1990.
17. Hayashi, K., and Yandell, D. W. How sensitive is PCR-SSCP? Hum. Mutat., 2, 338-346, 1993.
18. Higuchi, R. Recombinant PCR. In: M. A Innis, D. H. Gelfand, J J. Sninsky, and T J. White (eds.), PCR Protocols: A Guide to Methods and Applications, pp. 177-183, San Diego: Academic Press, Inc., 1990.
19. Sanger, F , Nicklen, S., and Coulson, A R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad Sci USA, 74: 5463-5467, 1977
20. Wyckoff, E , Natalie, D , Nolan, J. M , Lee, M., and Hsieh, T. Structure of the Drosophila DNA topoisomerase II gene Nucleotide sequence and homology among topoisomerases II. J. Mol. Biol., 205: 1-13, 1989.
21. Liu, L. F. DNA topoisomerase poisons as antitumor drugs. Annu. Rev. Biochem. 53 351-375, 1989.
22. Yamagishi, J., Yoshida, H., Yamayoshi, M , and Nakamura, S. Nalidixic acid-resistant mutations of the gyrB gene of Escherichia coli. Mol. Gen. Genet., 204: 367-373, 1986.